Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Go back to Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
(NASDAQ: OVID) Delayed: 2.69 --0 (-0%)
Previous Close $2.69    52 Week High
Open $2.69    52 Week Low
Day High $2.69    P/E N/A 
Day Low $2.69    EPS
Volume 20